ストックスクリーナーアプリを入手
87.05
0.71%
-0.5646
Merck Co Inc (MRK) 最新ニュース
Castle Rock Wealth Management LLC Buys Shares of 25,125 Merck & Co., Inc. $MRK - MarketBeat
Guild Investment Management Inc. Invests $3.18 Million in Merck & Co., Inc. $MRK - MarketBeat
Secured Retirement Advisors LLC Purchases Shares of 12,504 Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Louisiana State Employees Retirement System - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Kingswood Wealth Advisors LLC - MarketBeat
Merck, Doctors Reject Proposal To Break Up Combined MMR VaccineMerck & Co (NYSE:MRK) - Benzinga
KLP Kapitalforvaltning AS Has $102.21 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Shell Asset Management Co. Increases Stake in Merck & Co., Inc. $MRK - MarketBeat
Godsey & Gibb Inc. Buys 6,790 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co starts phase IIb study of tulisokibart in rheumatoid arthritis - MarketScreener
Merck Completes Acquisition of Verona Pharma - Business Wire
Seamount Financial Group Inc. Purchases Shares of 4,550 Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Grimes & Company Inc. - MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Lifted by SteelPeak Wealth LLC - MarketBeat
Merck Expands Tulisokibart Development In Pipeline-In-A-Product Race - insights.citeline.com
Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales - Benzinga
Zacks Value Trader Highlights: Pfizer, Merck, AbbVie, Eli Lilly and Novo Nordisk - The Globe and Mail
Merck Expands Tulisokibart Clinical Development Program With Initiation of Phase 2b Trials in Three Additional Immune-Mediated Inflammatory Diseases - Stock Titan
Merck & Co., Inc. $MRK Shares Bought by Cullinan Associates Inc. - MarketBeat
Merck & Co., Inc. $MRK Stock Position Raised by Plimoth Trust Co. LLC - MarketBeat
Merit Financial Group LLC Raises Holdings in Merck & Co., Inc. $MRK - MarketBeat
Ascent Group LLC Sells 38,049 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (MRK): A Bull Case Theory - MSN
OLD National Bancorp IN Acquires 46,762 Shares of Merck & Co., Inc. $MRK - MarketBeat
Simplicity Wealth LLC Buys 52,381 Shares of Merck & Co., Inc. $MRK - MarketBeat
Chemung Canal Trust Co. Buys 15,861 Shares of Merck & Co., Inc. $MRK - MarketBeat
Highland Capital Management LLC Increases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Talbot Financial LLC Buys 40,512 Shares of Merck & Co., Inc. $MRK - MarketBeat
Bernstein Maintains a Hold Rating on Merck & Co (MRK) - MSN
ZWJ Investment Counsel Inc. Decreases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
AMF Tjanstepension AB Sells 1,453,467 Shares of Merck & Co., Inc. $MRK - MarketBeat
Penobscot Investment Management Company Inc. Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
Bank Hapoalim BM Decreases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by NTV Asset Management LLC - MarketBeat
Precedent Wealth Partners LLC Acquires 3,259 Shares of Merck & Co., Inc. $MRK - MarketBeat
Ameritas Advisory Services LLC Sells 3,732 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck: A Race Against The Keytruda Clock (NYSE:MRK) - Seeking Alpha
What Does Wall Street Think About Merck & Co. (MRK)? - MSN
Sterling Investment Counsel LLC Has $474,000 Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Boosted by Synergy Asset Management LLC - MarketBeat
Syntax Research Inc. Sells 30,028 Shares of Merck & Co., Inc. $MRK - MarketBeat
Hilltop National Bank Buys Shares of 10,618 Merck & Co., Inc. $MRK - MarketBeat
MRK November 14th Options Begin Trading - Nasdaq
Is Most-Watched Stock Merck & Co., Inc. (MRK) Worth Betting on Now? - Yahoo Finance
Cliftonlarsonallen Wealth Advisors LLC Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Robeco Institutional Asset Management B.V. Raises Holdings in Merck & Co., Inc. $MRK - MarketBeat
Community Financial Services Group LLC Sells 42,545 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co (MRK) Announced Positive Results From Phase 3 HYPERION Trial of WINREVAIR - Insider Monkey
Merck (MRK) Jumps 6.8% on Trump Tariffs, Stellar Pulmonary Hypertension Drug Trial - MSN
Eli Lilly, Merck Surge Among Wednesday’s Market Cap Stock Movers - Investing.com
Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30 - PharmiWeb.com
ABSSSI Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Glenmark Pharma, Melinta Therapeutics, Sandoz Inc, Paratek Pharma, AbbVie Inc., Allergan PLC, Merck & Co. Inc., Pfizer - The Globe and Mail
First Pacific Financial Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
European healthcare stocks surge as U.S. Pfizer deal reduces some uncertainty - Reuters
Merck & Co. Inc. stock outperforms competitors on strong trading day - MarketWatch
Bernstein Maintains a Hold Rating on Merck & Co. (MRK) - Insider Monkey
Merck (MRK) Shares Skyrocket, What You Need To Know - Yahoo Finance
Merck’s Keytruda Approval: What’s Next? - StocksToTrade
1.18%
0.07%
大文字化:
|
ボリューム (24 時間):